Subminimum Inhibitory Concentrations Tetracycline Antibiotics Induce Biofilm Formation in Minocycline-Resistant Klebsiella pneumonia by Affecting Bacterial Physical and Chemical Properties and Associated Genes Expression.
Tingting GuoLiying YangNa ZhouZichen WangChangchao HuanJun ZhouTao LinGuangyu BaoJian HuGuocai LiPublished in: ACS infectious diseases (2024)
Biofilm formation of Klebsiella pneumoniae can protect bacteria from antibiotics and is difficult to eradicate. Thus, the influence of subinhibitory concentrations of antibiotics on bacteria is becoming increasingly important. Our study showed that subminimum inhibitory concentrations (sub-MICs) of tetracycline antibiotics can increase biofilm formation in minocycline-resistant Klebsiella pneumoniae clinical strains. However, in the bacterial adhesion and invasion experiments, the adhesion and invasion ability decreased and the survival rate of Galleria mellonella increased. Under sub-MICs of tetracycline antibiotics treatment, abnormal stretching of bacteria was observed by scanning electron microscopy. Treatment with sub-MICs of tetracyclines leads to increased surface hydrophobicity and eDNA content and decreased outer membrane permeability. The expression levels of the fimA , luxS , qseB , and qseC genes decreased, the expression level of mrkA increased, and the expression level of acrA was inconsistent under different tetracycline antibiotics treatments. Together, our results suggested that the increase in Klebsiella pneumoniae biofilm formation caused by sub-MICs of tetracycline antibiotics may occur by affecting bacterial physical and chemical properties and associated genes expression.
Keyphrases
- biofilm formation
- escherichia coli
- klebsiella pneumoniae
- pseudomonas aeruginosa
- staphylococcus aureus
- candida albicans
- poor prognosis
- multidrug resistant
- binding protein
- genome wide
- physical activity
- electron microscopy
- mental health
- cystic fibrosis
- cell migration
- visible light
- transcription factor
- mass spectrometry
- acute respiratory distress syndrome
- replacement therapy